Trial Profile
A study evaluating pharmacokinetics of posaconazole in a real-life cohort of patients using a population approach
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2017
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- 01 Sep 2017 New trial record
- 28 Aug 2017 Results published in the Antimicrobial Agents and Chemotherapy